Regulated vascular smooth muscle cell death in vascular diseases
Cell Proliferation · 2024-11 · 57 (11)
DOI: 10.1111/cpr.13688 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cell Proliferation, online erschienen am 14.06.2024. Verfasst von Zheng Yin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Renmin Hospital of Wuhan University, Department of Geriatrics, Zhongnan Hospital of Wuhan University, Wuhan University, Wuh…. Hauptthemen laut MEDLINE: Muscle, Smooth, Vascular, Vascular Diseases, Myocytes, Smooth Muscle. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 165 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Youth Interdisciplinary Special Fund of Zhongnan Hospital of Wuhan University, Excellent Doctoral Program of Zhongnan Hospital of Wuhan University.
Abstract (Originalsprache)
Regulated cell death (RCD) is a complex process that involves several cell types and plays a crucial role in vascular diseases. Vascular smooth muscle cells (VSMCs) are the predominant elements of the medial layer of blood vessels, and their regulated death contributes to the pathogenesis of vascular diseases. The types of regulated VSMC death include apoptosis, necroptosis, pyroptosis, ferroptosis, parthanatos, and autophagy‐dependent cell death (ADCD). In this review, we summarize the current evidence of regulated VSMC death pathways in major vascular diseases, such as atherosclerosis, vascular calcification, aortic aneurysm and dissection, hypertension, pulmonary arterial hypertension, neointimal hyperplasia, and inherited vascular diseases. All forms of RCD constitute a single, coordinated cell death system in which one pathway can compensate for another during disease progression. Pharmacologically targeting RCD pathways has potential for slowing and reversing disease progression, but challenges remain. A better understanding of the role of regulated VSMC death in vascular diseases and the underlying mechanisms may lead to novel pharmacological developments and help clinicians address the residual cardiovascular risk in patients with cardiovascular diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Cardiology, Renmin Hospital of Wuhan University, Department of Geriatrics, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, China.
- Cardiovascular Research Institute, Wuhan University, Wuhan, China.
- Hubei Key Laboratory of Cardiology, Wuhan, China.
- Center for Healthy Aging, Wuhan University School of Nursing, Wuhan, China.
ORCID-Profile: Jun Wan
Förderung
- National Natural Science Foundation of China
- Youth Interdisciplinary Special Fund of Zhongnan Hospital of Wuhan University
- Excellent Doctoral Program of Zhongnan Hospital of Wuhan University
Zitieren
APA
Yin, Z., Zhang, J., Shen, Z., Qin, J. J., Wan, J., & Wang, M. (2024). Regulated vascular smooth muscle cell death in vascular diseases. Cell Proliferation, 57(11). https://doi.org/10.1111/cpr.13688
Vancouver
Yin Z, Zhang J, Shen Z, Qin JJ, Wan J, Wang M. Regulated vascular smooth muscle cell death in vascular diseases. Cell Proliferation. 2024;57(11). doi:10.1111/cpr.13688
BibTeX
@article{Yin2024,
author = {Yin, Zheng and Zhang, Jishou and Shen, Zican and Qin, Juan-Juan and Wan, Jun and Wang, Menglong},
title = {Regulated vascular smooth muscle cell death in vascular diseases},
journal = {Cell Proliferation},
year = {2024},
volume = {57},
number = {11},
doi = {10.1111/cpr.13688}
}
EUVIMED